Shiv S Pillai
Harvard University
H-index: 63
North America-United States
Top articles of Shiv S Pillai
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Response in Adults with Predominantly Antibody Deficiency | Clinical Infectious Diseases | Lennard YW Lee Stefan Rozmanowski Matthew Pang Andre Charlett Charlotte Anderson | 2022/2/1 |
Immunophenotypic Risk Factors for Low SARS-CoV-2 Immunization Response in Adults with Predominantly Antibody Deficiency over Five Total Vaccine Doses | Journal of Allergy and Clinical Immunology | Anna Zhang AHMED ELMOURSI Daniel Digiacomo Baijun Zhou Megha Tandon | 2024/2/1 |
SARS-CoV-2 Vaccine Response Following Five Total Vaccine Doses in Adult Patients with Predominantly Antibody Deficiency (PAD) | Journal of Allergy and Clinical Immunology | AHMED ELMOURSI Anna Zhang Daniel Digiacomo Baijun Zhou Megha Tandon | 2024/2/1 |
Evidence Circulating Microclots and Activated Platelets Contribute to Hyperinflammation Within Pediatric Post Acute Sequala of COVID | YK Okuducu B Boribong F Ellett S Hajizadeh M VanElzakker | 2024/5 | |
TB Collaboration in Autoimmunity, Infection, and Transplantation | Daniel DiToro Naoka Murakami Shiv Pillai | 2024/2/1 | |
Granzyme K–and amphiregulin-expressing cytotoxic T cells and activated extrafollicular B cells are potential drivers of IgG4-related disease | Journal of Allergy and Clinical Immunology | Risako Koga Takashi Maehara Ryuichi Aoyagi Ryusuke Munemura Yuka Murakami | 2024/4/1 |
Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis | Nature Communications | Feiyang Ma Pei-Suen Tsou Mehrnaz Gharaee-Kermani Olesya Plazyo Xianying Xing | 2024/1/3 |
An e-Xist-ential two-edged sword for women | Science Immunology | Zhenrui Zhang Shiv Pillai | 2024/3/1 |
Congenital T cell activation impairs transitional to follicular B cell maturation in humans | bioRxiv | Hugues Allard-Chamard Kirsty Hillier Michelle L Ramseier Alice Bertocchi Naoki Kaneko | 2024 |
Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre … | The Lancet Rheumatology | Cory A Perugino Zachary S Wallace Debra J Zack Shauna M Quinn Allen Poma | 2023/8/1 |
Author Correction: Human circulating CD24hi marginal zone B cells produce IgM targeting atherogenic antigens and confer protection from vascular disease | Nature Cardiovascular Research | Tanyaporn Pattarabanjird Anh Tram Nguyen Chantel McSkimming Huy Q Dinh Melissa A Marshall | 2023/12 |
Extrafollicular IgD− CD27− CXCR5− CD11c− DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19 | Cell Reports | Hugues Allard-Chamard Naoki Kaneko Alice Bertocchi Na Sun Julie Boucau | 2023/6/27 |
A twist in the tail: Of T cell subsets and disease | Journal of Experimental Medicine | Shiv Pillai | 2023/11/6 |
“Age could not wither her…” because of her cytotoxic CD4+ T cells? | Science Immunology | Thomas Guy Shiv Pillai | 2023/5/5 |
9 T Cells and COVID-19 | The COVID-19 Textbook: Science, Medicine and Public Health | Shiv Pillai | 2023/11/3 |
Does the SARS-CoV-2 spike really have an Achilles heel? | The Journal of Clinical Investigation | Shiv Pillai | 2023/4/17 |
Human circulating CD24hi marginal zone B cells produce IgM targeting atherogenic antigens and confer protection from vascular disease | Nature Cardiovascular Research | Tanyaporn Pattarabanjird Anh Tram Nguyen Chantel McSkimming Huy Q Dinh Melissa A Marshall | 2023/11 |
Is it bad, is it good, or is IgG4 just misunderstood? | Shiv Pillai | 2023/2/7 | |
Neither naïve nor anergic,“autoimmune” not allergic | Science Immunology | Elif Çakan Shiv Pillai | 2023/10/6 |
Antibody Response to SARS CoV-2 Immunization in Patients with Immunodeficiency | Journal of Allergy and Clinical Immunology | Daniel DiGiacomo Vivek Naranbhai Nancy Yang Tiffany Lam Anand Dighe | 2022/2/1 |
